English
详细内容 首页 > 研究进展 > 详细内容  
Isoniazid Conjugated Poly(lactide-co-glycolide): Long-term Controlled Drug Release and Tissue Regeneration for Bone Tuberculosis Therapy
发布时间:2015-10-26 点击次数:460次

Isoniazid Conjugated Poly(lactide-co-glycolide): Long-term Controlled Drug Release and Tissue Regeneration for Bone Tuberculosis Therapy

Bone tuberculosis (TB) is one of the most common extrapulmonary TB. Effective integration of chemotherapy and bone regeneration is an optimal solution for bone TB therapy. Herein, we produce a composite scaffold drug delivery system fabricated with an isoniazid conjugated star poly(lactide-co-glycolide) (PLGA-INH4) and β-TCP. The cytological assay indicated the composite system possesses good biocompatibility. The in vitro and in vivo drug release evaluations showed that the composite system can intactly release the pristine INH and maintain effective INH concentration in a controlled manner for more than 100 days, and achieve high localized drug concentration and low systemic drug concentration. The rabbit radius repair experiment testified the scaffold has good bone regeneration capacity. Our work demonstrate the composite system can simultaneously achieve localized long-term drug controlled release and bone regeneration, which provides a promising route for improved bone TB treatment.

 

文章链接:http://www.sciencedirect.com/science/article/pii/S0142961215001763

关闭
首页  |  实验室介绍  |  研究领域  |  研究人员  |  研究进展  |  开放基金  |  仪器设备  |  招聘启事  |  联系我们
版权所有 © 高分子物理与化学国家重点实验室
地址:北京市海淀区中关村北一街2号 邮编:100190  您是第 262196 位访问者